Last reviewed · How we verify
Vonoprazan ODT-1 or ODT-2 with Water — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Vonoprazan ODT-1 or ODT-2 with Water (Vonoprazan ODT-1 or ODT-2 with Water) — Phathom Pharmaceuticals, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Vonoprazan ODT-1 or ODT-2 with Water TARGET | Vonoprazan ODT-1 or ODT-2 with Water | Phathom Pharmaceuticals, Inc. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Vonoprazan ODT-1 or ODT-2 with Water CI watch — RSS
- Vonoprazan ODT-1 or ODT-2 with Water CI watch — Atom
- Vonoprazan ODT-1 or ODT-2 with Water CI watch — JSON
- Vonoprazan ODT-1 or ODT-2 with Water alone — RSS
Cite this brief
Drug Landscape (2026). Vonoprazan ODT-1 or ODT-2 with Water — Competitive Intelligence Brief. https://druglandscape.com/ci/vonoprazan-odt-1-or-odt-2-with-water. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab